Accessibility Skip to:
  • Accessibility Policy
  • Main Content
  • Main Menu
  • Contact

  • -A: Font Smaller
  • +A: Font Larger
  • Reset Font
  • High Contrast
  • Low Contrast
  • Reset Contrast
History:
You are here:
  • Grand Challenges Canada
  • >
  • Innovations
  • >
  • 0208-01
  • Français
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovative Financing
    • Innovations & Results
    • Annual Report
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
Grand Challenges Canada

Bold Ideas with Big Impact®

Browse our Innovations and Results
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovative Financing
    • Innovations & Results
    • Annual Report
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
  • Accessibility
  • Contact
  • Français

Home » Innovations » 0208-01

Grow-your-own bacterial defenders against waterborne diseases

FacebookTwitterLinked In

Start Date: 01/04/2013- End Date: 31/12/2014


Project Lead(s): David McMillen

Issue

Many diseases are caused by ingesting bacteria from the environment.

Cholera, for example, is caused by ingesting Vibrio cholerae, usually from contaminated water supplies.

Many bacteria have viruses that prey on them, infecting the bacterial cells, using their cellular machinery to make many more copies of the virus, then bursting the cell to release the viruses back into the environment. 

Solution

This project investigated the potential to use bacteriophages (a virus that infects and replicates within a bacterium), as a means of targeting disease-causing bacteria for destruction. 

In principle, it may one day be possible to have engineered bacteria reside in the digestive tract of people at risk of exposure to a disease like cholera. The engineered cells would lie in wait until they sensed the presence of their target organism and, once detected, respond by triggering the release of bacteriophages to kill the incoming disease-causing organisms.

Because bacteria are self-replicating, they can be grown locally with minimal infrastructure.

The project used non-pathogenic bacteria E. coli to mimic the target bacteria cholera. (Cholera bacteria could not be used in the lab conditions because of safety concerns.)

The first prototype system was designed using E. coli and the lambda bacteriophage, which targets E. coli and is a well-studied bacteriophage system.

To gain experience with the actual biological components of cholera itself, the team also created a system able to sense the quorum-sensing molecules released by V. cholerae, and respond by producing a visible output signal.

To avoid working directly with V. cholerae, genes involved in production of the quorum sensing molecules were imported into E. coli cells, and these were used as a source of quorum sensing molecules.

Outcome

Preliminary results suggest that the system will be able to successfully respond to V. cholerae’s signals, though more work is needed to couple this system to the other components.

The team also implemented the bacteriophage lambda prototype system in E. coli cells, and demonstrated that the cells could be triggered to burst on command, releasing viruses into their environment. 

While this approach is promising, there is considerably more research required before any kind of clinical trial or commercial development can be undertaken.

Stay in touch with this innovator

  • Organization Website
  • Network Website
  • Innovation Overview
    Program

    Stars in Global Health

    Institution

    University of Toronto

    Institution Country

    Canada

    Implementation Country

    Philippines

    Implementation Region

    South Asia

    Priority

    Cholera, Infectious Diseases, Other

    Platform

    Drug

Grand Challenges Canada’s programs are primarily undertaken with the financial support of the Government of Canada provided through Global Affairs Canada.

Government of Canada
  • Fluxx Technical Support
  • Privacy Policy
  • Website Legal Terms and Disclaimer
We use cookies on our website to give you the most relevant experience by remembering your preferences and activity on our website. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may click on "Cookie Settings" to select the cookies applicable to your activity and disable those that do not. Please note that you will not be able to disable all cookies as some are necessary for the functioning of the website.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT